COMBINATION THERAPY WITH VOLASERTIB

• 收藏
• 分享

专利权人:

发明人:

Tillmann TAUBE

申请号：

US15448660

公开号：

US20170173023A1

申请日:

2017.03.03

申请国别(地区):

US

年份:

2017

代理人:

摘要：

Disclosed is the use of Volasertib or a salt or a hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising administering a high dose of Volasertib in combination with fludarabine, cytarabine and Granulocyte colony-stimulating factor (GCSF) or in combination with fludarabine, cytarabine, GCSF and a daunorubicin citrate liposome injection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/